| Dr Alberto Perez Romero, | |
|
Carretera 987 Hacia Las Croabas,, Santa Isidra #216, Fajardo, PR 00738 | |
| (787) 860-6153 | |
| Not Available |
| Full Name | Dr Alberto Perez Romero |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | Carretera 987 Hacia Las Croabas,, Fajardo, Puerto Rico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508081035 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 11504 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alberto Perez Romero, Calle 5 D-7, Urb. Santa Isidra I, Fajardo, PR 00738 Ph: (787) 860-3101 | Dr Alberto Perez Romero, Carretera 987 Hacia Las Croabas,, Santa Isidra #216, Fajardo, PR 00738 Ph: (787) 860-6153 |
News Archive
Ligand Pharmaceuticals Incorporated announced today that its partner Pfizer, Inc. has granted a sublicense to a multi-national pharmaceutical company for Tanaproget, also known as NSP-989. As a result, Ligand will receive an upfront payment of $1 million from Pfizer. Ligand is entitled to clinical and regulatory milestone payments from Pfizer as Tanaproget advances through the development process, as well as tiered royalties on net sales.
Across 5 days in August (3rd-7th), scientists from around the world gathered virtually to present and discuss new information on the role of the chemical senses in disease, nutrition, and social interactions in humans and animals.
A University of Manchester-led study is testing whether an intervention with parents and teachers can help children with autism transfer newly acquired social communication skills from home into school.
Amgen today announced that detailed results from two pivotal Phase 3 studies evaluating Vectibix® (panitumumab) in combination with chemotherapy for the first and second-line treatment of metastatic colorectal cancer (mCRC) (the PRIME '203' and '181' trials, respectively) will be presented at the 2010 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in Orlando, Florida from Jan. 22-24, 2010.
› Verified 3 days ago
Hildeberto Blasco, MD General Practice Medicare: Medicare Enrolled Practice Location: Ave Principal Baralt # F4, Fajardo, PR 00738 Phone: 787-860-5002 | |
Dr. Juan Luis Vazquez, MD General Practice Medicare: Medicare Enrolled Practice Location: 404 Ave General Valero, Fajardo, PR 00738 Phone: 787-988-9431 | |
Arturo Ortiz Ramos, General Practice Medicare: Accepting Medicare Assignments Practice Location: Calle Union #63, Fajardo, PR 00738 Phone: 787-863-4363 | |
Arturo Hernandez Estrlla, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: Centro Pediatrico De Fajardo, Urb Montr Brisa Calle E Suite 77, Fajardo, PR 00738 Phone: 787-801-1992 Fax: 787-863-5437 | |
Dr. Benjamin Ricardo Velazquez, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: Ave Principal G 19 Urb Baralt, Fajardo, PR 00738 Phone: 787-801-7710 Fax: 787-801-7710 | |
Dr. Howard John Wetterer, M.D. General Practice Medicare: Medicare Enrolled Practice Location: Ave. General Valero 313, Suite A, Fajardo, PR 00738 Phone: 787-801-3158 Fax: 787-801-3159 | |
Dr. Samuel Negron Agosto, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: Calle Cipres #706 Local #2, Fajardo Gardens, Fajardo, PR 00738 Phone: 787-801-4698 Fax: 787-801-4698 |